Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
OWC Pharmaceutical Research Corp., which operates through its subsidiary One World Cannabis Ltd., primarily focuses on the research and development of cannabis-based medical products. The company is dedicated to developing cannabis-derived therapies for a variety of conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD), chronic pain, and fibromyalgia. It is also innovating with a cannabis soluble tablet delivery system. Furthermore, OWC Pharmaceutical extends its expertise by providing consulting services to both private companies and governmental agencies on international medical cannabis protocols and regulatory frameworks. Founded in 2008 as Dynamic Applications Corp., the company adopted its current name, OWC Pharmaceutical Research Corp., in December 2014. Its headquarters are located in Ramat Gan, Israel.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is undervalued on EV/EBITDA.